NASDAQ : ALXO
ALX Oncology Holdings Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.22 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 168.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 20.96M | 23.85M | 26.09M | 28.48M | 29.04M | 23.39M |
| Research & Development | 61.83M | 77.00M | 116.37M | 141.79M | 98.40M | 60.17M |
| Operating Expenses | 82.79M | 100.85M | 142.47M | 170.28M | 127.44M | 83.56M |
| Operating Income | -82.79M | -100.85M | -142.47M | -170.28M | -127.44M | -83.56M |
| Interest Expense | -1.41M | -1.60M | -1.73M | -1.56M | -238.00K | -13.00K |
| Interest & Investment Income | 4.07M | 3.96M | 9.37M | 10.65M | 4.28M | 91.00K |
| Currency Exchange Gain (Loss) | 141.00K | -36.00K | -20.00K | 389.00K | ||
| Other Non Operating Income (Expenses) | 13.00K | -22.00K | -7.00K | |||
| EBT Excluding Unusual Items | -79.98M | -98.52M | -134.85M | -160.81M | -123.42M | -83.48M |
| Asset Writedown | -3.17M | |||||
| Other Unusual Items | -666.00K | |||||
| Pretax Income | -80.89M | -101.69M | -134.85M | -160.81M | -123.42M | -83.48M |
| Income Tax Expense | 64.00K | -21.00K | ||||
| Net Income | -80.89M | -101.69M | -134.85M | -160.81M | -123.48M | -83.46M |
| Net Income to Common | -80.89M | -101.69M | -134.85M | -160.81M | -123.48M | -83.46M |
| Shares Outstanding (Basic) | 86.69M | 53.66M | 52.17M | 42.99M | 40.70M | 40.31M |
| Shares Outstanding (Diluted) | 86.69M | 53.66M | 52.17M | 42.99M | 40.70M | 40.31M |
| EPS (Basic) | -0.93 | -1.90 | -2.58 | -3.74 | -3.03 | -2.07 |
| EPS (Diluted) | -0.93 | -1.90 | -2.58 | -3.74 | -3.03 | -2.07 |
| Free Cash Flow | -70.95M | -84.35M | -122.36M | -131.64M | -90.65M | -68.77M |
| Free Cash Flow Per Share | -0.82 | -1.57 | -2.35 | -3.06 | -2.23 | -1.71 |
| EBITDA | -82.30M | -100.14M | -141.59M | -169.44M | -127.09M | -83.50M |
| D&A For EBITDA | 495.00K | 706.00K | 872.00K | 836.00K | 342.00K | 51.00K |
| EBIT | -82.79M | -100.85M | -142.47M | -170.28M | -127.44M | -83.56M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 22.69M | 16.37M | 17.57M | 22.41M | 48.82M | 363.67M |
| Short-Term Investments | 115.54M | 28.42M | 110.19M | 160.33M | 217.38M | |
| Cash & Short-Term Investments | 138.23M | 44.79M | 127.76M | 182.74M | 266.21M | 363.67M |
| Other Receivables | 1.17M | 298.00K | 892.00K | 996.00K | ||
| Receivables | 1.17M | 298.00K | 892.00K | 996.00K | ||
| Prepaid Expenses | 3.52M | 5.62M | 5.68M | 4.49M | 4.76M | 3.35M |
| Other Current Assets | 542.00K | 20.00K | 27.00K | 439.00K | ||
| Total Current Assets | 143.46M | 50.73M | 134.35M | 188.66M | 270.97M | 367.02M |
| Property, Plant & Equipment | 1.44M | 3.87M | 9.63M | 10.84M | 9.81M | 3.47M |
| Long-Term Investments | 15.15M | 3.49M | 3.52M | 35.41M | 16.70M | |
| Other Long-Term Assets | 780.00K | 953.00K | 267.00K | 7.64M | 9.01M | 9.69M |
| Total Assets | 160.82M | 59.05M | 147.78M | 242.55M | 306.49M | 380.18M |
| Accounts Payable | 3.02M | 4.91M | 4.50M | 8.59M | 8.07M | 3.76M |
| Accrued Expenses | 8.89M | 10.55M | 9.26M | 15.44M | 10.79M | 9.60M |
| Current Portion of Long-Term Debt | 5.22M | 435.00K | ||||
| Current Portion of Leases | 1.25M | 1.86M | 742.00K | |||
| Other Current Liabilities | 1.62M | 2.01M | 4.30M | 11.97M | 9.46M | 1.19M |
| Total Current Liabilities | 14.78M | 24.55M | 18.50M | 36.00M | 28.32M | 15.29M |
| Long-Term Debt | 9.71M | 4.53M | 9.47M | 9.64M | 9.39M | |
| Long-Term Leases | 87.00K | 3.16M | ||||
| Other Long-Term Liabilities | 65.00K | 820.00K | 6.19M | 7.20M | 5.31M | 1.84M |
| Total Liabilities | 24.63M | 33.06M | 34.16M | 52.84M | 43.02M | 17.13M |
| Common Stock | 138.00K | 54.00K | 53.00K | 50.00K | 41.00K | 41.00K |
| Additional Paid-In Capital | 894.99M | 748.72M | 734.41M | 675.68M | 589.74M | 564.99M |
| Retained Earnings | -758.72M | -722.82M | -621.12M | -486.27M | -325.47M | -201.99M |
| Comprehensive Income & Other | -224.00K | 28.00K | 275.00K | 256.00K | -845.00K | |
| Total Common Equity | 136.19M | 25.98M | 113.62M | 189.71M | 263.46M | 363.05M |
| Shareholders' Equity | 136.19M | 25.98M | 113.62M | 189.71M | 263.46M | 363.05M |
| Total Liabilities & Equity | 160.82M | 59.05M | 147.78M | 242.55M | 306.49M | 380.18M |
| Total Debt | 11.04M | 14.77M | 9.90M | 9.64M | 9.39M | 742.00K |
| Net Cash (Debt) | 127.19M | 30.02M | 117.85M | 173.10M | 256.82M | 362.93M |
| Net Cash Per Share | 1.47 | 0.56 | 2.26 | 4.03 | 6.31 | 9.00 |
| Filing Date Shares Outstanding | 138.28M | 131.61M | 53.38M | 50.15M | 40.86M | 40.63M |
| Total Common Shares Outstanding | 138.22M | 54.39M | 53.05M | 49.95M | 40.86M | 40.59M |
| Working Capital | 128.68M | 26.17M | 115.85M | 152.66M | 242.64M | 351.72M |
| Book Value Per Share | 0.99 | 0.48 | 2.14 | 3.80 | 6.45 | 8.94 |
| Tangible Book Value | 136.19M | 25.98M | 113.62M | 189.71M | 263.46M | 363.05M |
| Tangible Book Value Per Share | 0.99 | 0.48 | 2.14 | 3.80 | 6.45 | 8.94 |
| Machinery | 880.00K | 2.47M | 2.47M | 2.31M | 1.93M | 731.00K |
| Leasehold Improvements | 224.00K | 709.00K | 2.51M | 2.51M | 2.36M | 229.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -80.89M | -101.69M | -134.85M | -160.81M | -123.48M | -83.46M |
| Depreciation & Amortization | 495.00K | 706.00K | 872.00K | 836.00K | 342.00K | 51.00K |
| Other Amortization | 278.00K | 280.00K | 265.00K | 250.00K | 44.00K | |
| Loss (Gain) From Sale of Assets | 246.00K | 10.00K | ||||
| Asset Writedown & Restructuring Costs | 3.17M | |||||
| Loss (Gain) From Sale of Investments | -945.00K | -1.24M | -4.66M | -6.49M | -940.00K | |
| Stock-Based Compensation | 10.42M | 12.58M | 27.09M | 26.27M | 23.84M | 13.91M |
| Other Operating Activities | -120.00K | 1.72M | 1.78M | 1.27M | 1.12M | 5.42M |
| Change in Accounts Payable | -1.96M | 421.00K | -4.02M | 458.00K | 4.51M | 3.29M |
| Change in Other Net Operating Assets | 1.70M | -85.00K | -8.41M | 7.84M | 5.34M | -7.32M |
| Operating Cash Flow | -70.78M | -84.14M | -121.91M | -130.36M | -89.22M | -68.10M |
| Capital Expenditures | -172.00K | -212.00K | -447.00K | -1.27M | -1.43M | -666.00K |
| Sale of Property, Plant & Equipment | 44.00K | |||||
| Sale (Purchase) of Intangibles | -4.26M | |||||
| Investment in Securities | -65.76M | 82.80M | 86.70M | 45.93M | -233.99M | |
| Investing Cash Flow | -65.89M | 82.59M | 86.26M | 44.66M | -235.42M | -4.92M |
| Long-Term Debt Issued | 10.00M | |||||
| Long-Term Debt Repaid | -1.36M | -827.00K | -388.00K | -388.00K | -281.00K | |
| Net Debt Issued (Repaid) | 6.03M | -1.36M | -827.00K | -388.00K | 9.61M | -281.00K |
| Issuance of Common Stock | 150.80M | 38.00K | 1.98M | 64.04M | 903.00K | 2.75M |
| Other Financing Activities | -16.58M | 1.69M | 29.66M | -4.36M | -655.00K | |
| Financing Cash Flow | 140.25M | 362.00K | 30.82M | 59.29M | 9.86M | 2.47M |
| Net Cash Flow | 3.58M | -1.19M | -4.84M | -26.42M | -314.78M | -70.55M |
| Free Cash Flow | -70.95M | -84.35M | -122.36M | -131.64M | -90.65M | -68.77M |
| Free Cash Flow Per Share | -0.82 | -1.57 | -2.35 | -3.06 | -2.23 | -1.71 |
| Levered Free Cash Flow | -41.16M | -50.61M | -80.95M | -74.80M | -44.64M | -36.42M |
| Unlevered Free Cash Flow | -40.55M | -49.89M | -80.13M | -74.07M | -44.53M | -36.41M |
| Cash Interest Paid | 1.26M | 1.26M | 1.39M | 1.18M | 103.00K | 11.00K |
| Cash Income Tax Paid | 274.00K | |||||
| Change in Working Capital | -261.00K | 336.00K | -12.43M | 8.30M | 9.85M | -4.03M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 168.70M | 61.27M | 88.08M | 741.80M | 459.31M | 870.34M |
| Enterprise Value | 41.51M | 16.25M | -43.14M | 566.82M | 181.02M | 488.10M |
| Last Close Price | 1.22 | 1.13 | 1.67 | 14.89 | 11.27 | 21.49 |
| PB Ratio | 1.24 | 2.36 | 0.78 | 3.91 | 1.74 | 2.40 |
| P/TBV Ratio | 1.24 | 2.36 | 0.78 | 3.91 | 1.74 | 2.40 |
| Debt / Equity Ratio | 0.08 | 0.57 | 0.09 | 0.05 | 0.04 | 0.00 |
| Net Debt / Equity Ratio | -0.93 | -1.16 | -1.04 | -0.91 | -0.97 | -1.00 |
| Net Debt / EBITDA Ratio | 1.55 | 0.30 | 0.83 | 1.02 | 2.02 | 4.35 |
| Net Debt / FCF Ratio | 1.79 | 0.36 | 0.96 | 1.31 | 2.83 | 5.28 |
| Quick Ratio | 9.43 | 1.84 | 6.95 | 5.10 | 9.40 | 23.78 |
| Current Ratio | 9.71 | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 |
| Return on Equity (ROE) | -80.65% | -145.70% | -88.91% | -70.97% | -39.42% | -21.05% |
| Return on Assets (ROA) | -40.40% | -60.95% | -45.62% | -38.77% | -23.20% | -12.80% |
| Return on Capital Employed (ROCE) | -56.70% | -292.40% | -110.20% | -82.40% | -45.80% | -22.90% |
| Earnings Yield | -76.48% | -165.99% | -153.10% | -21.68% | -26.88% | -9.59% |
| FCF Yield | -42.06% | -137.68% | -138.92% | -17.75% | -19.74% | -7.90% |
| Buyback Yield / Dilution | -61.42% | -2.84% | -21.37% | -5.62% | -0.97% | -118.05% |